SCHEMBL3603097

SCHEMBL3603097

COC(=O)c1cc(-c2nnnn2C)c(C(=O)OC)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
POLB P06746 2/20 0.41
OPRD1 P41143 1/20 0.40
PKM P14618 1/20 0.40
ABCC9 O60706 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
KCNJ8 Q15842 1/20 0.38
CSNK2A2 P19784 1/20 0.38
KDR P35968 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
HIF1A Q16665 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 7/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603100 0.93 NPC1 (0.40) NPC1RAB9APOLBOPRD1PKM
SCHEMBL3612431 0.82 SMN1; SMN2 (0.41) PKMABCC9ABCC8KCNJ11KCNJ8
SCHEMBL3596170 0.78 IKBKB (0.55) NPC1RAB9APOLBABCC9ABCC8
SCHEMBL3608683 0.76 MAPK8 (0.42) NPC1RAB9APOLBOPRD1PKM
SCHEMBL3609536 0.72 OPRD1 (0.54) NPC1RAB9AOPRD1PKMSMN1; SMN2
SCHEMBL3608687 0.69 MAPK8 (0.42) NPC1POLBOPRD1PKMSMN1; SMN2
SCHEMBL3613774 0.69 HSD11B1 (0.47) NPC1RAB9AHIF1ANPSR1RXFP1
SCHEMBL3606367 0.69 PDE4D (0.41) POLBHIF1ANPSR1RXFP1ALDH1A1
SCHEMBL4606149 0.68 ATAD2 (0.51) NPC1RAB9APOLBABCC9ABCC8
SCHEMBL3604669 0.67 MAPK14 (0.65) NPC1RAB9APKMNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 NPC1 2952/4885RAB9A 3435/4885POLB 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.